Target
Tyrosine-protein kinase Lck
Ligand
BDBM50045936
Substrate
n/a
Meas. Tech.
ChEBML_221490
IC50
5000±n/a nM
Citation
 Bullington, JLCameron, JCDavis, JEDodd, JHHarris, CAHenry, JRPellegrino-Gensey, JLRupert, KCSiekierka, JJ The development of novel and selective p56lck tyrosine kinase inhibitors. Bioorg Med Chem Lett 8:2489-94 (1999) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase Lck
Synonyms:
2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase
Type:
n/a
Mol. Mass.:
57987.83
Organism:
Homo sapiens (Human)
Description:
P06239
Residue:
509
Sequence:
MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP
  
Inhibitor
Name:
BDBM50045936
Synonyms:
(E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol | (E)-Piceatannol | 3,3',4,5'-tetrahydroxystilbene | 3,4,3',5'-tetrahydroxy-trans-stilbene | 3,4,3',5'-tetrahydroxystillbene | 4-(3,5-dihydroxystyryl)benzene-1,2-diol | 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol | 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol(Piceatannol) | 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol | 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol(Piceatannol) | CHEMBL69863 | NSC-365798 | US11866416, Example 8 | cid_667639 | piceatanol | trans-3,3',4,5'-tetrahydroxystilbene
Type:
Small organic molecule
Emp. Form.:
C14H12O4
Mol. Mass.:
244.2427
SMILES:
Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1
Structure:
Search PDB for entries with ligand similarity: